Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13053 | 799 | 36.8 | 49% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1822 | 5688 | POMPE DISEASE//GLYCOGEN STORAGE DISEASE TYPE II//GLYCOGEN STORAGE DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLYCOGEN PHOSPHORYLASE | Author keyword | 54 | 32% | 18% | 142 |
2 | GLYCOGEN PHOSPHORYLASE INHIBITOR | Author keyword | 11 | 65% | 1% | 11 |
3 | STARCH PHOSPHORYLASE | Author keyword | 7 | 33% | 2% | 17 |
4 | CARDIOVASC METAB DIS BIOL | Address | 6 | 80% | 1% | 4 |
5 | GLUCAN PHOSPHORYLASE | Author keyword | 5 | 60% | 1% | 6 |
6 | MUSCLE GLYCOGEN PHOSPHORYLASE B | Author keyword | 5 | 60% | 1% | 6 |
7 | ALPHA 1 4 GLUCAN PHOSPHORYLASE | Author keyword | 4 | 75% | 0% | 3 |
8 | CELL BIOL SIGNALING GRPHUNGARIAN SCI | Address | 4 | 75% | 0% | 3 |
9 | G 1 P | Author keyword | 4 | 75% | 0% | 3 |
10 | GLYCOGEN PHOSPHORYLASE B | Author keyword | 4 | 31% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BETA D GLUCOPYRANOSYLAMINE | 49 | 94% | 2% | 17 |
2 | GLUCOSE ANALOG INHIBITORS | 32 | 62% | 4% | 33 |
3 | TYPE 2 DIABETES THERAPY | 32 | 78% | 3% | 21 |
4 | POTENTIAL ANTIDIABETIC DRUG | 21 | 90% | 1% | 9 |
5 | POTENTIAL ANTIDIABETIC AGENTS | 19 | 80% | 2% | 12 |
6 | GLUCOPYRANOSYLIDENE SPIRO THIOHYDANTOIN | 19 | 61% | 3% | 20 |
7 | SPIROHYDANTOIN | 17 | 62% | 2% | 18 |
8 | ALLOSTERIC SITE | 17 | 32% | 6% | 44 |
9 | COENZYME FORMS | 15 | 82% | 1% | 9 |
10 | COLI MALTODEXTRIN PHOSPHORYLASE | 12 | 46% | 2% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Glycogen phosphorylase inhibitors: a patent review (2008-2012) | 2013 | 7 | 90 | 76% |
GLYCOGEN-PHOSPHORYLASE - CONTROL BY PHOSPHORYLATION AND ALLOSTERIC EFFECTORS | 1992 | 177 | 33 | 70% |
New Inhibitors of Glycogen Phosphorylase as Potential Antidiabetic Agents | 2008 | 80 | 155 | 53% |
Advances in glycogen phosphorylase inhibitor design | 2008 | 48 | 53 | 77% |
New hepatic targets for glycaemic control in diabetes | 2007 | 75 | 97 | 39% |
Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes | 2014 | 4 | 117 | 62% |
Inhibition of Glycogen Phosphorylase in the Context of Type 2 Diabetes, with Focus on Recent Inhibitors Bound at the Active Site | 2010 | 32 | 141 | 53% |
Recent Advances in the Allosteric Inhibition of Glycogen Phosphorylase | 2010 | 20 | 115 | 74% |
The Prototype of Glycogen Phosphorylase | 2010 | 20 | 57 | 74% |
Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: Recent developments | 2003 | 143 | 72 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOVASC METAB DIS BIOL | 6 | 80% | 0.5% | 4 |
2 | CELL BIOL SIGNALING GRPHUNGARIAN SCI | 4 | 75% | 0.4% | 3 |
3 | CHIM ORGAN 2UMR 5246 | 2 | 67% | 0.3% | 2 |
4 | EXPLORATORY MED BIOL | 2 | 67% | 0.3% | 2 |
5 | MED CHEMMED HLTH SCI | 2 | 67% | 0.3% | 2 |
6 | BIOL 48 VAS CONSTANTINOU AVE | 2 | 50% | 0.4% | 3 |
7 | HEPAT BIOCHEM | 2 | 50% | 0.4% | 3 |
8 | METAB EXCELLENCE DRUG DISCOVERY | 2 | 50% | 0.4% | 3 |
9 | CARDIOVASC METAB DIS MED CHEM | 1 | 50% | 0.3% | 2 |
10 | CHIM BIOCHIM MOL SUPRAMOL ASSOCIE | 1 | 50% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000206907 | PHOSPHORYLASE KINASE//PHOSPHORYLASE KINASE DEFICIENCY//GLYCOGEN STORAGE DISEASE TYPE IX |
2 | 0.0000127397 | SUCROSE PHOSPHORYLASE//EPILACTOSE//CELLOBIOSE 2 EPIMERASE |
3 | 0.0000110894 | MCARDLES DISEASE//MCARDLE DISEASE//MYOPHOSPHORYLASE |
4 | 0.0000097525 | GLYCOGENIN//MACROGLYCOGEN//PROGLYCOGEN |
5 | 0.0000091984 | SUGAR AMINO ACIDS//SUGAR AMINO ACID//CARBOHYDRATE SCAFFOLDS |
6 | 0.0000085243 | PROTEIN PHOSPHATASE 1//INHIBITOR 2//GLYCOGEN SYNTHASE |
7 | 0.0000067652 | AMINOPOLYSTYRENE//BETA GLYCOPYRANOSYLAMINES//BETA N ACETYLGLUCOSAMINYL L ASPARAGINE ANALOGUES |
8 | 0.0000062563 | STARCH SYNTHASE//STARCH BRANCHING ENZYME//GRANULE BOUND STARCH SYNTHASE |
9 | 0.0000059236 | ENZYME TECHNOL GRP//MODIFIED ENZYME//BIOTECHNOL STUDIES |
10 | 0.0000055610 | GLYCOTECHNOL BUSINESS UNIT//STRUCT GLYCOBIOL SECT//BACTERIAL SIALYLTRANSFERASE |